Integration of Azenta Life Sciences BioStore™ III automated storage and inventory monitoring solution with Cytiva’s Chronicle™ software will improve traceability, process control, and monitoring capabilities.
Cytiva, a global life sciences leader, and Azenta Life Sciences, a former division of Brooks Automation, are working together to expand Cytiva’s Chronicle software capabilities to seamlessly integrate Azenta Life Sciences BioStore III automated storage platform, which is purpose built to handle a wide range of high value materials between the temperatures of -20°C and -190°C in an efficient, documented way. Chronicle software will provide a unified digital platform that can electronically trace cellular products and raw materials through the cell therapy workflow including the cryogenic cold chain
Chronicle software is a fit-for-purpose solution designed to optimize complex cell therapy process development and manufacturing. It provides real-time supply chain tracking, hardware performance monitoring, SMS or email alarms, and comprehensive electronic batch manufacturing records (eBMRs). The eBMRs enable a manufacturer to define a sequence of eSOPs (electronic standard operating procedures), which are designed for specific processes to manage deviations, promote adherence to protocol, and provide guidance to ensure sensitive patient cells are handled appropriately. Built by platform solution engineers, Chronicle integrates with a variety of third-party instruments and has been independently audited against GAMP™ 5, 21 CFR Part 11, and EU Annex 11.
Linda De Jesus, Vice President and Chief Commercial Officer, Azenta Life Sciences, says: “By integrating a freezer platform like the BioStore III with Cytiva’s Chronicle software, we are helping customers add the documented rigor around cold chain, inventory and handling which previously did not exist. This integrated solution will allow customers to expand the role of automation in their workflows and documentation to help bring products to the market faster.”
Catarina Flyborg, Vice President, Cytiva, says: “Cell therapies are showing tremendous promise to transform human health, but the lack of automation is hampering manufacture and distribution. The integration of Chronicle software with Azenta Life Sciences BioStore III confirms the need for flexible solutions that can connect third-party instruments across complex manufacturing ecosystems.”
Interested customers can reach out to Cytiva and Azenta Life Sciences for a product demonstration immediately.
For more information about Cytiva’s cell therapy solutions, please click here.
To read more about the BioStore III and Chronicle integration, and to submit inquiries, please click here.
Cytiva is a global life sciences leader with more than 7,000 associates across 40 countries dedicated to advancing and accelerating therapeutics. As a trusted partner to customers that range in scale and scope, Cytiva brings speed, efficiency and capacity to research and manufacturing workflows, enabling the development, manufacture and delivery of transformative medicines to patients.
About Azenta Life Sciences
Azenta Life Sciences is a leading provider of life science sample-based solutions. As a service provider to labs around the world, Azenta Life Sciences offers a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Azenta Life Sciences' GENEWIZ division is a leading provider of DNA gene sequencing and gene synthesis services. The organization is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia